Illumina, Inc.’s $1 Billion Revolving Credit Facility and $300 Million Registered Senior Notes Offering 

Cravath represented Illumina, Inc. in connection with its $1 billion revolving credit facility. Illumina, Inc. is a global leader in sequencing- and array‑based solutions for genetic and genomic analysis. The transaction closed on August 13, 2026.

Cravath also represented Illumina, Inc. in connection with its $300 million registered senior notes offering. The transaction closed on August 17, 2026.

The Cravath team included partners George E. Zobitz and Christopher J. Kelly and associate Steven T. Marzagalli on banking matters; partners Andrew J. Pitts and C. Daniel Haaren and associates Courtney T. Seager, Ryan W. Herrmann and Han Wen Zhang on capital markets matters; and partner Arvind Ravichandran and associates Ruth Goldstein Schapiro, Yasmeen Shrestha and Andrew Stone on tax matters.